SAR-299155

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameSAR-299155
Drug Alias Namep53-HDM2 protein interaction inhibitor (Sanofi/Ascenta Therapeutics)SAR-299155MI-77301
ClassificationSmall molecules
Mechanisms of ActionTumor protein p53 stimulantsp53-binding protein Mdm-2 inhibitors
Targetsp53-binding protein Mdm-2Tumor protein p53
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesFrance
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesSanofi
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSanofiAscenta Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A